Literature DB >> 33552314

Inflammatory and Adipokine Status from Early to Midpregnancy in Arab Women and Its Associations with Gestational Diabetes Mellitus.

Sara Al-Musharaf1, Shaun Sabico2, Syed Danish Hussain2, Fatima Al-Tawashi2, Haifa Bandar AlWaily3, Nasser M Al-Daghri2, Philip McTernan4.   

Abstract

OBJECTIVE: To examine differences in maternal serum levels of adipokines (adiponectin, leptin, and resistin) and inflammatory markers (tumor necrosis factor-alpha (TNF-α) and interlukin-6 (IL-6)) from early to midpregnancy among Arab women with or without gestational diabetes mellitus (GDM), along with their links to GDM risk.
METHODS: This is a multicenter prospective study involving 232 Saudi women attending obstetric care. Both circulating adipokine and markers of inflammation were observed at the first (eight to 12 weeks) and second trimesters (24 to 28 weeks). GDM was screened at 24 to 28 weeks using the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) criteria.
RESULTS: Age and body mass index- (BMI-) matched circulating TNF-α was significantly higher in women with GDM in comparison to non-GDM women (p = 0.01). Adiponectin and resistin significantly decreased from the first to second trimester in women without GDM (p = 0.002 and 0.026, respectively). Leptin presented a significant rise from the first to second trimester in both groups, with a higher increase in women with GDM (p = 0.013). Multivariate logistic regression analysis revealed that TNF-α was significantly correlated with GDM (p = 0.03). However, significance was lost after adjustments for maternal and lifestyle risk factors (OR 23.58 (0.50 to 1119.98), p = 0.11).
CONCLUSION: Inflammatory and adipocytokine profiles are altered in Arab women with GDM, TNF-α in particular. Further studies are needed to establish whether maternal inflammatory and adipocytokine profile influence fetal levels in the same manner.
Copyright © 2021 Sara Al-Musharaf et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33552314      PMCID: PMC7847332          DOI: 10.1155/2021/8862494

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  43 in total

Review 1.  Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia.

Authors:  Konstanze Miehle; Holger Stepan; Mathias Fasshauer
Journal:  Clin Endocrinol (Oxf)       Date:  2012-01       Impact factor: 3.478

2.  Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitus.

Authors:  C López-Tinoco; M Roca; A Fernández-Deudero; A García-Valero; F Bugatto; M Aguilar-Diosdado; J L Bartha
Journal:  Cytokine       Date:  2011-12-24       Impact factor: 3.861

3.  Risk stratification in early pregnancy for women at increased risk of gestational diabetes.

Authors:  C L Harrison; C B Lombard; C East; J Boyle; H J Teede
Journal:  Diabetes Res Clin Pract       Date:  2014-09-30       Impact factor: 5.602

Review 4.  Early Pregnancy Biochemical Predictors of Gestational Diabetes Mellitus.

Authors:  Camille E Powe
Journal:  Curr Diab Rep       Date:  2017-02       Impact factor: 4.810

Review 5.  Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials.

Authors:  J Sonya Haw; Karla I Galaviz; Audrey N Straus; Alysse J Kowalski; Matthew J Magee; Mary Beth Weber; Jingkai Wei; K M Venkat Narayan; Mohammed K Ali
Journal:  JAMA Intern Med       Date:  2017-12-01       Impact factor: 21.873

6.  Variations of tumor necrosis factor-alpha, leptin and adiponectin in mid-trimester of gestational diabetes mellitus.

Authors:  Xue-lian Gao; Hui-xia Yang; Yi Zhao
Journal:  Chin Med J (Engl)       Date:  2008-04-20       Impact factor: 2.628

7.  A prospective study of maternal serum C-reactive protein (CRP) concentrations and risk of gestational diabetes mellitus.

Authors:  Chunfang Qiu; Tanya K Sorensen; David A Luthy; Michelle A Williams
Journal:  Paediatr Perinat Epidemiol       Date:  2004-09       Impact factor: 3.980

8.  Adiponectin and leptin as first trimester markers for gestational diabetes mellitus: a cohort study.

Authors:  Ida Näslund Thagaard; Lone Krebs; Jens-Christian Holm; Theis Lange; Torben Larsen; Michael Christiansen
Journal:  Clin Chem Lab Med       Date:  2017-10-26       Impact factor: 3.694

9.  SPRING: an RCT study of probiotics in the prevention of gestational diabetes mellitus in overweight and obese women.

Authors:  Marloes Dekker Nitert; Helen L Barrett; Katie Foxcroft; Anne Tremellen; Shelley Wilkinson; Barbara Lingwood; Jacinta M Tobin; Chris McSweeney; Peter O'Rourke; H David McIntyre; Leonie K Callaway
Journal:  BMC Pregnancy Childbirth       Date:  2013-02-25       Impact factor: 3.007

Review 10.  Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis.

Authors:  Jie Xu; Yan Hong Zhao; Yun Ping Chen; Xiao Lei Yuan; Jiao Wang; Hui Zhu; Chun Mei Lu
Journal:  ScientificWorldJournal       Date:  2014-08-19
View more
  2 in total

Review 1.  New Insights into Adipokines in Gestational Diabetes Mellitus.

Authors:  Jorge Valencia-Ortega; Rebeca González-Reynoso; Edgar G Ramos-Martínez; Aldo Ferreira-Hermosillo; María I Peña-Cano; Enrique Morales-Ávila; Renata Saucedo
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

2.  Angiogenic Imbalance and Inflammatory Biomarkers in the Prediction of Hypertension as Well as Obstetric and Perinatal Complications in Women with Gestational Diabetes Mellitus.

Authors:  Almudena Lara-Barea; Begoña Sánchez-Lechuga; Antonio Campos-Caro; Juan Antonio Córdoba-Doña; Raquel de la Varga-Martínez; Ana I Arroba; Fernando Bugatto; Manuel Aguilar-Diosdado; Cristina López-Tinoco
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.